- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about JNJ
Recent news which mentions JNJ
NVIDIA's New AI System Aims To Transform Genetic Research With Unmatched Speed And Precision
February 20, 2025
From Benzinga
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
February 19, 2025
From Benzinga
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
February 18, 2025
From Benzinga
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
From Benzinga
Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study
February 13, 2025
From Benzinga
Congress Member Josh Gottheimer Dumps Nvidia, Microsoft, Loads Up On Tesla Stocks Instead
February 12, 2025
From Benzinga
P/E Ratio Insights for Johnson & Johnson
February 12, 2025
From Benzinga
Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates
February 12, 2025
From Benzinga
Warren Buffett's Granddaughter Claimed He Cut Her Off And She Couldn't Afford Health Insurance: 'He Disowned My Twin Sister And Myself'
February 09, 2025
Tickers
JNJ
From Benzinga
2 Stocks to Buy if There Is a Market Crash in 2025
February 09, 2025
From Motley Fool
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
February 08, 2025
From Motley Fool
Eli Lilly's Recently Approved Inflammatory Bowel Disease Drug Shows Sustained And Durable Treatment At Two Years
February 07, 2025
From Benzinga
Kenvue's Q4 Sales Miss, Margins Improve
February 06, 2025
From Motley Fool
Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?
February 01, 2025
Tickers
JNJ
From Motley Fool
From Motley Fool
Johnson & Johnson's Options Frenzy: What You Need to Know
January 30, 2025
Tickers
JNJ
From Benzinga
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
January 29, 2025
From Benzinga
From Benzinga
From Benzinga
Georgia Rep. Marjorie Taylor Greene Bought Up to $45K Worth of Johnson & Johnson Stock
January 28, 2025
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2025
From Benzinga
These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024
January 25, 2025
From Motley Fool
From Motley Fool
Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?
January 23, 2025
From Motley Fool
Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
January 23, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.